<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/936D002F-A8D1-4A93-AE5D-825ED0903D8D"><gtr:id>936D002F-A8D1-4A93-AE5D-825ED0903D8D</gtr:id><gtr:name>University of Nottingham</gtr:name><gtr:address><gtr:line1>University Park</gtr:line1><gtr:line4>Nottingham</gtr:line4><gtr:line5>Nottinghamshire</gtr:line5><gtr:postCode>NG7 2RD</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/0A32DF0B-F2C5-42D5-A74A-32E1FD6B47D1"><gtr:id>0A32DF0B-F2C5-42D5-A74A-32E1FD6B47D1</gtr:id><gtr:name>University of Massachusetts (UMass)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/20E66A18-4A43-4DD5-BA98-5320F6EC9269"><gtr:id>20E66A18-4A43-4DD5-BA98-5320F6EC9269</gtr:id><gtr:name>GlaxoSmithKline (GSK)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/DDD14154-81FB-417E-81AA-AAEA066ECA04"><gtr:id>DDD14154-81FB-417E-81AA-AAEA066ECA04</gtr:id><gtr:name>The Wellcome Trust  Sanger Institute</gtr:name><gtr:address><gtr:line1>Wellcome Trust Genome Campus</gtr:line1><gtr:line2>Hinxton</gtr:line2><gtr:postCode>CB10 1SA</gtr:postCode><gtr:region>East of England</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/0AEFDD04-383A-4977-9F05-440376448760"><gtr:id>0AEFDD04-383A-4977-9F05-440376448760</gtr:id><gtr:name>International Centre for Genetic Engineering and Biotechnology</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/5FEE5E83-79D6-4AD2-970E-F076F1AC08A7"><gtr:id>5FEE5E83-79D6-4AD2-970E-F076F1AC08A7</gtr:id><gtr:name>Biodim Laboratory</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/37EF6C9C-5F51-40DD-BED5-B792981BC119"><gtr:id>37EF6C9C-5F51-40DD-BED5-B792981BC119</gtr:id><gtr:name>Imperial Cancer Research Fund</gtr:name><gtr:address><gtr:line1>44 Lincoln's Inn Fields</gtr:line1><gtr:postCode>WC2A 3PX</gtr:postCode><gtr:region>London</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/64F5B912-92CD-489B-A071-6CA22EFAAAA9"><gtr:id>64F5B912-92CD-489B-A071-6CA22EFAAAA9</gtr:id><gtr:name>Weizmann Institute of Science</gtr:name><gtr:address><gtr:line1>PO Box 26</gtr:line1><gtr:line2>Rehovot 76100</gtr:line2><gtr:line4>Rehovot</gtr:line4><gtr:postCode>76100</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Israel</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/CD6AF5C3-2280-4421-911E-1D68A6DFFE7C"><gtr:id>CD6AF5C3-2280-4421-911E-1D68A6DFFE7C</gtr:id><gtr:name>University of Wuerzburg</gtr:name><gtr:address><gtr:line1>Sanderring 2</gtr:line1><gtr:postCode>D-97070</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/453DB5AB-8BFE-4E0A-B761-1C39BD880D5D"><gtr:id>453DB5AB-8BFE-4E0A-B761-1C39BD880D5D</gtr:id><gtr:name>Scripps Research Institute</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/57150975-2FFC-442F-A99E-ABD25A46F8D2"><gtr:id>57150975-2FFC-442F-A99E-ABD25A46F8D2</gtr:id><gtr:name>Pasteur Institute, Paris</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:department>Immunology and Molecular Pathology</gtr:department><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/936D002F-A8D1-4A93-AE5D-825ED0903D8D"><gtr:id>936D002F-A8D1-4A93-AE5D-825ED0903D8D</gtr:id><gtr:name>University of Nottingham</gtr:name><gtr:address><gtr:line1>University Park</gtr:line1><gtr:line4>Nottingham</gtr:line4><gtr:line5>Nottinghamshire</gtr:line5><gtr:postCode>NG7 2RD</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/0A32DF0B-F2C5-42D5-A74A-32E1FD6B47D1"><gtr:id>0A32DF0B-F2C5-42D5-A74A-32E1FD6B47D1</gtr:id><gtr:name>University of Massachusetts (UMass)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/20E66A18-4A43-4DD5-BA98-5320F6EC9269"><gtr:id>20E66A18-4A43-4DD5-BA98-5320F6EC9269</gtr:id><gtr:name>GlaxoSmithKline (GSK)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/DDD14154-81FB-417E-81AA-AAEA066ECA04"><gtr:id>DDD14154-81FB-417E-81AA-AAEA066ECA04</gtr:id><gtr:name>The Wellcome Trust  Sanger Institute</gtr:name><gtr:address><gtr:line1>Wellcome Trust Genome Campus</gtr:line1><gtr:line2>Hinxton</gtr:line2><gtr:postCode>CB10 1SA</gtr:postCode><gtr:region>East of England</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/0AEFDD04-383A-4977-9F05-440376448760"><gtr:id>0AEFDD04-383A-4977-9F05-440376448760</gtr:id><gtr:name>International Centre for Genetic Engineering and Biotechnology</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5FEE5E83-79D6-4AD2-970E-F076F1AC08A7"><gtr:id>5FEE5E83-79D6-4AD2-970E-F076F1AC08A7</gtr:id><gtr:name>Biodim Laboratory</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/37EF6C9C-5F51-40DD-BED5-B792981BC119"><gtr:id>37EF6C9C-5F51-40DD-BED5-B792981BC119</gtr:id><gtr:name>Imperial Cancer Research Fund</gtr:name><gtr:address><gtr:line1>44 Lincoln's Inn Fields</gtr:line1><gtr:postCode>WC2A 3PX</gtr:postCode><gtr:region>London</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/64F5B912-92CD-489B-A071-6CA22EFAAAA9"><gtr:id>64F5B912-92CD-489B-A071-6CA22EFAAAA9</gtr:id><gtr:name>Weizmann Institute of Science</gtr:name><gtr:address><gtr:line1>PO Box 26</gtr:line1><gtr:line2>Rehovot 76100</gtr:line2><gtr:line4>Rehovot</gtr:line4><gtr:postCode>76100</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Israel</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/CD6AF5C3-2280-4421-911E-1D68A6DFFE7C"><gtr:id>CD6AF5C3-2280-4421-911E-1D68A6DFFE7C</gtr:id><gtr:name>University of Wuerzburg</gtr:name><gtr:address><gtr:line1>Sanderring 2</gtr:line1><gtr:postCode>D-97070</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/453DB5AB-8BFE-4E0A-B761-1C39BD880D5D"><gtr:id>453DB5AB-8BFE-4E0A-B761-1C39BD880D5D</gtr:id><gtr:name>Scripps Research Institute</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/57150975-2FFC-442F-A99E-ABD25A46F8D2"><gtr:id>57150975-2FFC-442F-A99E-ABD25A46F8D2</gtr:id><gtr:name>Pasteur Institute, Paris</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/D5568E1D-EFE4-448E-821B-3B135E754B5D"><gtr:id>D5568E1D-EFE4-448E-821B-3B135E754B5D</gtr:id><gtr:firstName>Yasuhiro</gtr:firstName><gtr:surname>Takeuchi</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/EBA4ABCD-0394-4234-8808-94480506F83D"><gtr:id>EBA4ABCD-0394-4234-8808-94480506F83D</gtr:id><gtr:firstName>Mary</gtr:firstName><gtr:surname>Collins</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0501446"><gtr:id>1366DAAC-1F3B-4D60-B5E5-C6C263E9FB7D</gtr:id><gtr:title>The universal lentiviral packaging cell</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0501446</gtr:grantReference><gtr:abstractText>Inherited diseases are caused by mistakes in the DNA of patients. In the case of rare inherited immunodeficiencies diseases (Baby in the Bubble syndrome), they can be cured by delivering a correct copy of the faulty DNA using an engineered virus (gene therapy). This project is to be carried out by scientists in the MRC/UCL Medical Molecular Virology Centre at UCL. They will develop a safer and more efficient method to produce engineered viruses for clinical gene therapy trials.</gtr:abstractText><gtr:technicalSummary>Lentiviral vectors integrate and express transgenes in most cells. Due to cytotoxicity of viral proteins vectors are currently produced by transient transfection. This is costly, laborious, inherently unsafe and hard to scale-up. We recently reported a prototype packaging cell that continuously produced high-titre lentiviral vectors (see key reference). We now request funding to produce a safe, easily manipulated packaging system suitable for clinical lentiviral vector production by the following strategy, using recombination mediated cassette exchange:
1. Infect 293T cells with an MLV vector containing a loxP site in LTR, then transient transfection of Cre recombinase and selectable lentiviral Gag-Pol cassettes.
2. Infect these cells with a second MLV vector containing an FRT site, then transfected with Flp recombinase and selectable lentiviral vector cassettes.
3. Gammaretroviral envelopes will be expressed, viral safety and immunogenicity will be tested.</gtr:technicalSummary><gtr:fund><gtr:end>2010-01-03</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2007-01-04</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>323831</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>The Wellcome Trust Sanger Institute</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Professor Mike Stratton and Dr Elisabeth Murchison, Wellcome Trust Sanger Institute</gtr:description><gtr:id>11CE54BE-A691-45DA-BAD3-3574436B71BA</gtr:id><gtr:impact>A paper describing the CTVT genome published in Science, another publication on the tumour transcriptional changes is in preparation.</gtr:impact><gtr:outcomeId>5457b4217ac7b4.58853469-1</gtr:outcomeId><gtr:partnerContribution>Provided data and expertise on the genome of CTVT</gtr:partnerContribution><gtr:piContribution>Provided data and expertise on the canine Venereal Transmissible Tumour (CTVT).</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Imperial College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Dr Marcus Dorner, Imperial College</gtr:description><gtr:id>2D877F47-881C-47B0-99C2-1E1D4BDCEB79</gtr:id><gtr:impact>experiments ongoing</gtr:impact><gtr:outcomeId>5457b3383d17e7.56862711-1</gtr:outcomeId><gtr:partnerContribution>Humanized mouse models for HIV-1 infection to test the effect of selective Hsp90 inhbitors on HIV-1 latency.</gtr:partnerContribution><gtr:piContribution>Provided data and expertise on the effect of Hsp90 on regulation of HIV-1 latency, provided specific Hsp90 inhibitor.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Pasteur Institute, Paris</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:description>Professor Olivier Schwartz, Pasteur Institute, Paris</gtr:description><gtr:id>3EE35A57-DC49-4F2B-AF72-CF844C6405D6</gtr:id><gtr:impact>One paper in PLoS Pathogens describing the effect of fever on HIV-1 replication and the role of Hsp90</gtr:impact><gtr:outcomeId>5457ac4d11b695.94540793-1</gtr:outcomeId><gtr:partnerContribution>Provided data and expertise on mechanisms contributing to enhanced HIV-1 replication during hyperthermia (fever).</gtr:partnerContribution><gtr:piContribution>Provided data and expertise on the role of Hsp90 in HIV-1 infection.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Biodim Laboratory</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:description>Discovery of new cellular targets for antiretroviral drug development (FASSATI)</gtr:description><gtr:id>A4E17F19-2333-49E6-BA5A-1659C8B6D732</gtr:id><gtr:impact>Eleven new hits identified to be followed up</gtr:impact><gtr:outcomeId>JqQZtLmmEDh-1</gtr:outcomeId><gtr:partnerContribution>Provided chemical library of 10,000 compounds to perform screening and cherry picked compounds.</gtr:partnerContribution><gtr:piContribution>Developed a novel cell-based, high through put screening assay. Discovered a new cell target important for HIV-1 infection.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Cancer Research UK</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Dr Peter Cherepanov, CRUK</gtr:description><gtr:id>4FBF7A8C-4EFD-46FD-89B7-F468DBFB2283</gtr:id><gtr:impact>One paper in PNAS</gtr:impact><gtr:outcomeId>5457ad8c644f58.76072307-1</gtr:outcomeId><gtr:partnerContribution>Structural biology of transportin 3.</gtr:partnerContribution><gtr:piContribution>provision of expression constructs recomninat protein expression and methods for immunoprecipitation. Expertise on nuclear transport receptors.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Llama VHHantobody fragments to neutralise viruses (WEISS)</gtr:description><gtr:id>6D9203A5-8854-4ED3-991E-7DB7B5BB1D4D</gtr:id><gtr:impact>Research papers and 1 patent filed</gtr:impact><gtr:outcomeId>bRwMQNRPNYh-1</gtr:outcomeId><gtr:partnerContribution>VHH technology</gtr:partnerContribution><gtr:piContribution>virology</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>GlaxoSmithKline (GSK)</gtr:collaboratingOrganisation><gtr:country>Global</gtr:country><gtr:description>Veronique Birault, GSK, Stevenage.</gtr:description><gtr:id>EBF599D3-F534-48BB-AB0F-685EA1BE9AA3</gtr:id><gtr:impact>In the process of performing SAR studies with GSK compounds</gtr:impact><gtr:outcomeId>5457b530bc2508.60866385-1</gtr:outcomeId><gtr:partnerContribution>Provided lead compounds that target the new host factor discovered by us.</gtr:partnerContribution><gtr:piContribution>Provided data on a new host factor to be used as an antiretroviral target.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Division of Infection and Immunity</gtr:department><gtr:description>Novel broadly neutralizing Llama VHH (FASSATI)</gtr:description><gtr:id>62227349-46EA-47D7-91E6-511C67952F73</gtr:id><gtr:impact>One paper to be submitted shortly.</gtr:impact><gtr:outcomeId>RvkADcwunwK-1</gtr:outcomeId><gtr:partnerContribution>Characterised VHH, area of binding, performed deep sequencing to demonstrate that novel VHH arised after immunization.</gtr:partnerContribution><gtr:piContribution>Developed and performed high through put screening to identify novel broadly neutralizing LLama VHH, identified three new VHH.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>International Centre for Genetic Engineering and Biotechnology</gtr:collaboratingOrganisation><gtr:country>Italy, Italian Republic</gtr:country><gtr:description>Hsp90 controls HIV-1 reactivation from latency (FASSATI)</gtr:description><gtr:id>854049B9-FEF0-494C-9D26-3A45671A1A34</gtr:id><gtr:impact>One paper in PLoS Path (2012), one invited review in Parasitology (to be submitted shortly), one manuscript submitted and one MRC grant application submitted in September 2013.</gtr:impact><gtr:outcomeId>TwYz4sMJM3z-2</gtr:outcomeId><gtr:partnerContribution>Discovered that hyperthermia stimulates HIV-1 replication and reactivation. Contributed imaging methods to visualise nuclear migration of Hsp90 and other components.</gtr:partnerContribution><gtr:piContribution>Discovered that Hsp90 is required for HIV-1 gene expression and reactivation from latency, described the pathway involved.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Division of Biosciences</gtr:department><gtr:description>Hsp90 controls HIV-1 reactivation from latency (FASSATI)</gtr:description><gtr:id>448D9DA3-13D0-4CD8-9816-516828E6E163</gtr:id><gtr:impact>One paper in PLoS Path (2012), one invited review in Parasitology (to be submitted shortly), one manuscript submitted and one MRC grant application submitted in September 2013.</gtr:impact><gtr:outcomeId>TwYz4sMJM3z-3</gtr:outcomeId><gtr:partnerContribution>Discovered that hyperthermia stimulates HIV-1 replication and reactivation. Contributed imaging methods to visualise nuclear migration of Hsp90 and other components.</gtr:partnerContribution><gtr:piContribution>Discovered that Hsp90 is required for HIV-1 gene expression and reactivation from latency, described the pathway involved.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Super-resolution imaging: probe development (GROVE)</gtr:description><gtr:id>BB48CE22-0B98-4BF9-A8D2-E1DB21785B56</gtr:id><gtr:impact>not yet known</gtr:impact><gtr:outcomeId>VS3hguu22DK-1</gtr:outcomeId><gtr:partnerContribution>Project conception, development and application</gtr:partnerContribution><gtr:piContribution>Project conception, development and application</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Nottingham</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Professor Christopher Moody and Dr Russell Kitson, University of Nottingham</gtr:description><gtr:id>D05C9B25-159B-4D9D-8C1A-698EF0A345FF</gtr:id><gtr:impact>One paper in PNAS</gtr:impact><gtr:outcomeId>5457af169abe74.94468630-1</gtr:outcomeId><gtr:partnerContribution>Provided new chemical compounds inhibitors of Hsp90</gtr:partnerContribution><gtr:piContribution>Provided data and expertise on the role of Hsp90 in HIV-1 latency.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Collaboration with Adrian Hill and Helen McShane Oxford supported by UCL CBRC grant (COLLINS)</gtr:description><gtr:id>9DEAE87A-ECC3-4434-B7F5-F20D1FDEE4F4</gtr:id><gtr:impact>in progress</gtr:impact><gtr:outcomeId>A82MeHbBbYV-1</gtr:outcomeId><gtr:partnerContribution>Novel adjuvant molecules, TB antigens and models</gtr:partnerContribution><gtr:piContribution>Lentiviral vectors</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Metbolism and Endocrinology</gtr:department><gtr:description>Dr Richard Benarous, Mutabilis, France</gtr:description><gtr:id>9B60FB1F-30F4-4E27-95C7-D9B8457E7CE8</gtr:id><gtr:impact>Identified four new compounds with antiretroviral activity: they belong to a new class of antiretrovirals .</gtr:impact><gtr:outcomeId>5457b6521ba981.38549373-1</gtr:outcomeId><gtr:partnerContribution>Provided expertise and library of 10,000 small chemical compounds selected from a 150,000 compounds library.</gtr:partnerContribution><gtr:piContribution>Performed novel high through put screening to identify host factos necessary for HIV-1 replication.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Wurzburg</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:description>Wuerzburg Collaboration (STAUSS)</gtr:description><gtr:id>FD6C451F-C35B-4EC9-8D44-CD04AB0EE466</gtr:id><gtr:impact>TBA</gtr:impact><gtr:outcomeId>cpYahGdnEHR-1</gtr:outcomeId><gtr:partnerContribution>TBA</gtr:partnerContribution><gtr:piContribution>TBA</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Pasteur Institute, Paris</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:description>Prof. Olivier Schwartz, Pasteur Institute, Paris (FASSATI)</gtr:description><gtr:id>AA37D659-EEBC-4EB9-A846-7CFB52A92F53</gtr:id><gtr:impact>One paper in PLoS Pathogens describing the effect of fever on HIV-1 replication and the role of Hsp90</gtr:impact><gtr:outcomeId>f5fSw2V8ESh-1</gtr:outcomeId><gtr:partnerContribution>Provided data and expertise on mechanisms contributing to enhanced HIV-1 replication during hyperthermia (fever)</gtr:partnerContribution><gtr:piContribution>Provided data and expertise on the role of Hsp90 in HIV-1 infection</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Scripps Research Institute</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Dennis Burton Lab Visit (MCCOY)</gtr:description><gtr:id>623BA414-A4DA-4EE4-8B81-F19D6D4B7183</gtr:id><gtr:impact>not known yet</gtr:impact><gtr:outcomeId>aBNE6YgB9XE-1</gtr:outcomeId><gtr:partnerContribution>This travel grant was used to accelerate a HIV antigen development project</gtr:partnerContribution><gtr:piContribution>This travel grant was used to accelerate a HIV antigen development project</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Biosciences</gtr:department><gtr:description>UCL Gene Therapy Consortium</gtr:description><gtr:id>10646AFF-E13B-4DD8-AD8F-44D821890826</gtr:id><gtr:impact>We have set up an MHRA accredited GMP production facility</gtr:impact><gtr:outcomeId>BC0C322FB27-1</gtr:outcomeId><gtr:partnerContribution>Provision of GMP viral production facilities</gtr:partnerContribution><gtr:piContribution>We are developing reagents and processes for clinical lentiviral vector production.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC National Institute for Medical Research (NIMR)</gtr:department><gtr:description>Dr. Ian Taylor, MRC NIMR, Mill Hill (FASSATI)</gtr:description><gtr:id>31EC0A6B-BE93-42B8-A7D3-E7CCC86398CC</gtr:id><gtr:impact>one paper in preparation</gtr:impact><gtr:outcomeId>fJ4246Npm7o-1</gtr:outcomeId><gtr:partnerContribution>co-crystal structure of Coumermycin-A1 and HIV-1 capsid protein</gtr:partnerContribution><gtr:piContribution>Provided data and expertise on the role of the antibiotic Coumermycin-A1 in blocking HIV-1 replication</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Pasteur Institute, Paris</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:description>Hsp90 controls HIV-1 reactivation from latency (FASSATI)</gtr:description><gtr:id>16AC6EE8-4E79-4B12-9C5C-7521240845FA</gtr:id><gtr:impact>One paper in PLoS Path (2012), one invited review in Parasitology (to be submitted shortly), one manuscript submitted and one MRC grant application submitted in September 2013.</gtr:impact><gtr:outcomeId>TwYz4sMJM3z-1</gtr:outcomeId><gtr:partnerContribution>Discovered that hyperthermia stimulates HIV-1 replication and reactivation. Contributed imaging methods to visualise nuclear migration of Hsp90 and other components.</gtr:partnerContribution><gtr:piContribution>Discovered that Hsp90 is required for HIV-1 gene expression and reactivation from latency, described the pathway involved.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>London Centre for Nanotechnology</gtr:department><gtr:description>Mechanism of viral transport across nuclear pores (FASSATI)</gtr:description><gtr:id>549A611F-0DB2-4A47-AB2D-314163D921DE</gtr:id><gtr:impact>One modelling paper (Phys. Rev. E. 2012), one review (Soft Matter 2013), one paper to be submitted shortly.</gtr:impact><gtr:outcomeId>GypEAdBAEgA-1</gtr:outcomeId><gtr:partnerContribution>Atomic force microscopy and physical modelling of nuclear pores.</gtr:partnerContribution><gtr:piContribution>Expertise on nucleo-cytoplasmic trafficking of viruses and large molecules.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>GlaxoSmithKline (GSK)</gtr:collaboratingOrganisation><gtr:country>Global</gtr:country><gtr:description>Discovery of new cellular targets for antiretroviral drug development (FASSATI)</gtr:description><gtr:id>39BC2A4E-932C-4EF5-9944-BBC12B3C40EE</gtr:id><gtr:impact>in the process of testing the compounds</gtr:impact><gtr:outcomeId>osYUkdksaMH-1</gtr:outcomeId><gtr:partnerContribution>Provided novel lead compounds that inhibit the target identified in our high through put screening</gtr:partnerContribution><gtr:piContribution>Developed a novel high through put screening, cell-based assay. Discovered a new cell target important for HIV</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Weizmann Institute of Science</gtr:collaboratingOrganisation><gtr:country>Israel, State of</gtr:country><gtr:description>Population dynamics of T cell responses analysed using high-throughput sequencing of TCR repertoire (CHAIN)</gtr:description><gtr:id>22C93C6B-CBD6-4525-95EB-1D1F8A5A03FC</gtr:id><gtr:impact>Still in progress</gtr:impact><gtr:outcomeId>YHN3NvnfLJg-1</gtr:outcomeId><gtr:partnerContribution>Immunisations and seqeuncing</gtr:partnerContribution><gtr:piContribution>Developemnt of software for seqeunce analysis.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Imperial College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Professor Charles Bangham, Imperial College</gtr:description><gtr:id>AF978003-6E26-439E-9CC5-BB3B207C1AFD</gtr:id><gtr:impact>One paper in preparation, one grant application submitted to MRC.</gtr:impact><gtr:outcomeId>5457b2501774e5.76621581-1</gtr:outcomeId><gtr:partnerContribution>High through put sequencing of HIV-1 integration sites.</gtr:partnerContribution><gtr:piContribution>Discovered new host factor involved in HIV-1 replication that affects integration site selection.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Centre for Medical Molecular Virology</gtr:department><gtr:description>Professor Benny Chain, UCL and MRC Centre</gtr:description><gtr:id>DC090B9D-FDE6-49D1-867E-34121CAD346B</gtr:id><gtr:impact>One MSc Thesis (Tse Wang) and one paper published in the journal Traffic</gtr:impact><gtr:outcomeId>5457ab20a51f24.87271310-1</gtr:outcomeId><gtr:partnerContribution>Provided data and expertise on biophysical properties of transfected DNA and on innate Immunity.</gtr:partnerContribution><gtr:piContribution>Provided data and expertise on nuclear import of DNA.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Massachusetts (UMass)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Raymond Welsh Lab Visit (PEPPA)</gtr:description><gtr:id>B13C1BC2-06C4-41CD-A22E-1B028C242B96</gtr:id><gtr:impact>not yet known</gtr:impact><gtr:outcomeId>MjPBRLnXn2u-1</gtr:outcomeId><gtr:partnerContribution>development of valuable collaboration, also link with a planned project on regulatory potential of NK cells in HBV with the MRC unit in the Gambia</gtr:partnerContribution><gtr:piContribution>address how T cell regulation by NK cells contribute to overall disease pathogenesis</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Understanding the coordination of hepatitis C virus entry and humoral immune evasion (GROVE)</gtr:description><gtr:id>E178D472-9213-408F-B280-E36058678697</gtr:id><gtr:impact>not yet known</gtr:impact><gtr:outcomeId>LkAuGKtuzmr-1</gtr:outcomeId><gtr:partnerContribution>Access to clinical samples</gtr:partnerContribution><gtr:piContribution>Project conception, development and application</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>School Visit Primrose Hill (STAUSS)</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>5B85F354-2557-4006-8CDC-69FB738679AA</gtr:id><gtr:impact>Parents attended a presentation of our research and all children attended an assembly

money raised for cancer research</gtr:impact><gtr:outcomeId>YBeV66JFrWi</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Institute of Immunity and Transplantation Opening Symposium (GROVE)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>A696A53E-99B2-4FBC-8C44-F4F2E345A06F</gtr:id><gtr:impact>The symposium was filmed and I worked with a video editor to create a digital version of the presentation for You Tube</gtr:impact><gtr:outcomeId>jFrjQxtVRof</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Lecture on the AIDS epidemic for the charity &quot;Mothers to Mothers&quot; London. (A. Fassati)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>83CD2C19-A69B-45F3-A926-F1B0BF53E416</gtr:id><gtr:impact>to be added</gtr:impact><gtr:outcomeId>545a4faae7f4d3.96174765</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.m2m.org</gtr:url><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Lecture to Y6 children &quot;Investigating microbes&quot; at the Oratory RC Primary School, London. (A. Fassati)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>5D5F17A5-494D-442B-9259-CE5EEE735336</gtr:id><gtr:impact>to be added</gtr:impact><gtr:outcomeId>545a4d88a239c4.34174376</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Lecture &quot;Conscience and values in the response to infectious diseases&quot;, Thomas More Institute, London. (A. Fassati)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>9369883F-05E2-486C-8883-F85E41724612</gtr:id><gtr:impact>to be added</gtr:impact><gtr:outcomeId>545a4ef0d3d475.73242472</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://thomasmoreinstitute.org.uk/papers/conscience-and-values-in-the-response-toinfectious-diseases/</gtr:url><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Talk</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>22B00B9C-084F-4618-B915-7F0345E078D9</gtr:id><gtr:impact>I have talked about this work at several national and international gene therapy meetings and posters have been presented

applications to work in the lab, PhD student recruitment</gtr:impact><gtr:outcomeId>62A3015DF24</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2007,2008,2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Mayflower &amp; Gayhurst Primary schools visits 2012 (TOWERS/MILNE)</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>81BBF5B8-CE25-4896-8B59-1BD06393AB69</gtr:id><gtr:impact>Centre members visited local schools and presented an interactive talk about virology. Pupils asked many questions and the Centre received thank you letters expressing their increases interest in science and had a unique opportunity to do real lab-based tasks.</gtr:impact><gtr:outcomeId>oQdCZa47d1T</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>HIV &amp; AIDS (WEISS)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>F66C3D50-E951-4E86-AE13-F115EA895910</gtr:id><gtr:impact>too soon to say</gtr:impact><gtr:outcomeId>Yynt4xSYLKL</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Talk in Bloomsbury Festival (M COLLINS)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>85BA7F5B-B0A6-4AD8-8FF3-998CB4758CC6</gtr:id><gtr:impact>Cosy Science, &amp;quot;viruses are our friends&amp;quot;, The Marquis of Cornwallis pub, 2013 for 50+ local residents

raised public awareness</gtr:impact><gtr:outcomeId>rjJ3xB6Jpyc</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Carolton Primary School Visit 2012 (TOWERS/MILNE)</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>7D53D468-68D1-416B-8AAE-138A6623C030</gtr:id><gtr:impact>40 local school children attended open day in the Centre labs; consisted of interactive introductory talk, followed by lab rotations where pupils preformed DNA extractions, microscope work, pipetting skills, artwork. Pupils asked many questions and the Centre received thank you letters expressing their increases interest in science and had a unique opportunity to do real lab-based tasks.</gtr:impact><gtr:outcomeId>LYRo1vX4bhv</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Live comment on the origin of the AIDS epidemic on Arise News (A. Fassati)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>5E63D9D0-5940-48B7-BD68-C344C2282309</gtr:id><gtr:impact>to be added</gtr:impact><gtr:outcomeId>545a4ceb7ae763.69277745</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:url>http://www.arise.tv/arise-news-show/africa-wrap-03-10-8501</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Public lecture (STAUSS)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>AF447450-3F24-45B8-B173-414A423B89D5</gtr:id><gtr:impact>Approximately 200 lay people attended lecture on T Cell therapy

Lecture was recorded and is available on You-tube</gtr:impact><gtr:outcomeId>WAaSXnz3BP6</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Mayflower &amp; Gayhurst Primary School visits 2013 (TOWERS/MILNE)</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>5A8845E1-588A-4137-8589-27193C0FC2A8</gtr:id><gtr:impact>Centre members visited local schools and presented an interactive talk about virology. Pupils asked many questions and the Centre received thank you letters expressing their increases interest in science and had a unique opportunity to do real lab-based tasks.</gtr:impact><gtr:outcomeId>kRKg9aLvttF</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Lunchtime Lecture UCL (COLLINS)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>58A7F5E7-4F03-47E4-9462-F6A1A2A5F426</gtr:id><gtr:impact>800 You tube hits</gtr:impact><gtr:outcomeId>Sp3KFk8iPsm</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>MRC@UCL Centenary Science Fair (ALL MEMBERS)</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>EBCB7481-4E9D-4936-8E52-27D72F5D8487</gtr:id><gtr:impact>500+ members of the public (families, adults, school children) attended a science fair held @ UCL, Centre members contributed 3 hands-on workshop stalls, and presented separate talks. The public were given opportunities to perform tasks associated with the work of the Centre, and asked questions/contributed to discussions about what the Centre does and general science queries. Feedback included saying children had increased interest in developing their science education and awareness of virology principles.</gtr:impact><gtr:outcomeId>p3GGr2CsPNH</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Contribution to the Financial Times &quot;New synthetic life needs context and regulation&quot;(A. Fassati)</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>46CE7C74-2927-46F8-A207-DE6486B5B235</gtr:id><gtr:impact>to be added</gtr:impact><gtr:outcomeId>545a503dc26947.02633876</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:url>http://www.ft.com/cms/s/0/3da6db20-6796-11df-a932-00144feab49a.html#axzz2hsOEkNfY</gtr:url><gtr:year>2010</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>520000</gtr:amountPounds><gtr:country>Hungary, Republic of</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Biological Research Centre (BRC)</gtr:department><gtr:description>UCLH BRC Funding for Wolfson Gene Therapy Unit, 2013-2016 (M. Collins)</gtr:description><gtr:end>2016-01-02</gtr:end><gtr:fundingOrg>Hungarian Academy of Sciences (MTA)</gtr:fundingOrg><gtr:id>D8CEAD2D-FF88-41E9-9A18-DC03123645C6</gtr:id><gtr:outcomeId>546229937c0661.25620922</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2000000</gtr:amountPounds><gtr:country>Germany, Federal Republic of</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Biomedical Resource</gtr:description><gtr:end>2012-12-02</gtr:end><gtr:fundingOrg>German Federal Ministry of Education and Research</gtr:fundingOrg><gtr:id>50E56F54-C1F7-4CFD-8A6F-CA4EF8BE218F</gtr:id><gtr:outcomeId>3C9BA53891C0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>6000000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:department>Seventh Framework Programme (FP7)</gtr:department><gtr:description>EU FP7 HEALTH 2012 INNOVATION-1 (STAUSS)</gtr:description><gtr:end>2015-10-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:id>0615AC52-CBBE-40D3-9E98-D869A248130A</gtr:id><gtr:outcomeId>Mb3Ap4HxJFk</gtr:outcomeId><gtr:sector>Public</gtr:sector></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>In order to make large ammounts of lentiviral vectors for clinical use, a stable cell line production system is necessary. In this project we have made a GMP compatible cell line expressing higher levels of HIV gag-pol than previously reported by our group and others. We are now completing the work.</gtr:description><gtr:id>FD790B1E-C1F7-4709-B03A-87361F1B4695</gtr:id><gtr:impact>Too soon. These cells will be useful when we finish them</gtr:impact><gtr:outcomeId>669B3344A93</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Lentiviral packaging cell</gtr:title><gtr:type>Cell line</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>3328AD4A-88D6-4F81-9E66-834CE4B6B58E</gtr:id><gtr:title>Insertional gene activation by lentiviral and gammaretroviral vectors.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1ab4da35500c37c9a6636262fe3ac039"><gtr:id>1ab4da35500c37c9a6636262fe3ac039</gtr:id><gtr:otherNames>Bokhoven M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>1C10FE4106E</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C89F7BD6-9BDF-497F-8FAF-E2E1E28423C9</gtr:id><gtr:title>Comparison of lentiviral and sleeping beauty mediated a? T cell receptor gene transfer.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/650f1d8cfe4962f9cd8bede5aa155319"><gtr:id>650f1d8cfe4962f9cd8bede5aa155319</gtr:id><gtr:otherNames>Field AC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>546202c21bc206.65344493</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D0A210C8-5ABB-4F06-A5E7-C13C79DF1FAD</gtr:id><gtr:title>DNA fusion vaccine designs to induce tumor-lytic CD8+ T-cell attack via the immunodominant cysteine-containing epitope of NY-ESO 1.</gtr:title><gtr:parentPublicationTitle>International journal of cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/442b429f6b5f836091635bace93c3863"><gtr:id>442b429f6b5f836091635bace93c3863</gtr:id><gtr:otherNames>Campos-Perez J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0020-7136</gtr:issn><gtr:outcomeId>54622623713e18.18968055</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C0F6160B-DB23-44CE-B931-D9F630C5D051</gtr:id><gtr:title>Gene therapy strategies to exploit TRIM derived restriction factors against HIV-1.</gtr:title><gtr:parentPublicationTitle>Viruses</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f89c7b4622f2153cac81da53204ade0e"><gtr:id>f89c7b4622f2153cac81da53204ade0e</gtr:id><gtr:otherNames>Chan E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1999-4915</gtr:issn><gtr:outcomeId>545cef60192577.23622094</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>34BAEAB3-FBD4-436B-8230-D5295A2E4931</gtr:id><gtr:title>A model for cofactor use during HIV-1 reverse transcription and nuclear entry.</gtr:title><gtr:parentPublicationTitle>Current opinion in virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7d849bcff7512ae0e8f595615237a927"><gtr:id>7d849bcff7512ae0e8f595615237a927</gtr:id><gtr:otherNames>Hilditch L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1879-6257</gtr:issn><gtr:outcomeId>545ceeaa89d427.79976674</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0E475AB6-4936-49DC-BD77-5F7A55625926</gtr:id><gtr:title>Mode of virus rescue determines the acquisition of VHS mutations in VP22-negative herpes simplex virus 1.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0a487439957a8a457771f1264aa85442"><gtr:id>0a487439957a8a457771f1264aa85442</gtr:id><gtr:otherNames>Ebert K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>545ba859051401.20404011</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8B8C8CC4-1DDD-4DE0-B1E8-1D60CA434E57</gtr:id><gtr:title>Structural basis for nuclear import of splicing factors by human Transportin 3.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/67c749d627f6a6bccbe386923cc5a048"><gtr:id>67c749d627f6a6bccbe386923cc5a048</gtr:id><gtr:otherNames>Maertens GN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>545b9c82716285.11668961</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>25935406-FDA4-460D-A8ED-12F637291B66</gtr:id><gtr:title>p38 signaling inhibits mTORC1-independent autophagy in senescent human CD8? T cells.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical investigation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/eeadefcfa805429fe4021215f24d5f0f"><gtr:id>eeadefcfa805429fe4021215f24d5f0f</gtr:id><gtr:otherNames>Henson SM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0021-9738</gtr:issn><gtr:outcomeId>54621ad0047f29.65636332</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>73A34F73-FC4E-42D3-BB31-38B189BBA384</gtr:id><gtr:title>4-1BB ligand activates bystander dendritic cells to enhance immunization in trans.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e8005ca9db27435e99e117da5712d43"><gtr:id>5e8005ca9db27435e99e117da5712d43</gtr:id><gtr:otherNames>Macdonald DC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>544fbc32a45524.97945788</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>58F4273E-2C81-4FE8-84CC-B201BE32FB5F</gtr:id><gtr:title>Next-generation whole genome sequencing identifies the direction of norovirus transmission in linked patients.</gtr:title><gtr:parentPublicationTitle>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c18528a81eb674069f4bfa80db10e10c"><gtr:id>c18528a81eb674069f4bfa80db10e10c</gtr:id><gtr:otherNames>Kundu S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1058-4838</gtr:issn><gtr:outcomeId>545ba609eca5c9.06288860</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>728F2B45-7266-4502-A5D8-FDFA24714BCA</gtr:id><gtr:title>Inhibition of retroviral replication by members of the TRIM protein family.</gtr:title><gtr:parentPublicationTitle>Current topics in microbiology and immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4163edd090b7f7934101c6c7f3ffd2b9"><gtr:id>4163edd090b7f7934101c6c7f3ffd2b9</gtr:id><gtr:otherNames>Fletcher AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0070-217X</gtr:issn><gtr:outcomeId>545cf5bd1f1674.44388746</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>31BB6872-8486-4EBF-B342-FE8FA833E2FA</gtr:id><gtr:title>Early antigen presentation of protective HIV-1 KF11Gag and KK10Gag epitopes from incoming viral particles facilitates rapid recognition of infected cells by specific CD8+ T cells.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f5c2d35d76a3ff3436246776122a7aa9"><gtr:id>f5c2d35d76a3ff3436246776122a7aa9</gtr:id><gtr:otherNames>Kl?verpris HN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>545cf71c966f37.69980824</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>10C1D2B8-EFE7-4BB7-A5FE-D0EEFA89CF0D</gtr:id><gtr:title>Transmissible [corrected] dog cancer genome reveals the origin and history of an ancient cell lineage.</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9fe58dc6a098327a26c6ec7f9af7dc38"><gtr:id>9fe58dc6a098327a26c6ec7f9af7dc38</gtr:id><gtr:otherNames>Murchison EP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn><gtr:outcomeId>545b9cb3576192.99381322</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AFA9D1BC-A684-4339-8DB8-A0B1CFD21C45</gtr:id><gtr:title>Tetherin restricts herpes simplex virus 1 and is antagonized by glycoprotein M.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/16e46d4f7f3d0fd5771d96152a22af04"><gtr:id>16e46d4f7f3d0fd5771d96152a22af04</gtr:id><gtr:otherNames>Blondeau C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>545cf0d84bdcb4.52927387</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3B34A27E-C229-4E11-92B1-27DDA064292D</gtr:id><gtr:title>HLA-specific intracellular epitope processing shapes an immunodominance pattern for HLA-B*57 that is distinct from HLA-B*58:01.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f5c2d35d76a3ff3436246776122a7aa9"><gtr:id>f5c2d35d76a3ff3436246776122a7aa9</gtr:id><gtr:otherNames>Kl?verpris HN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>545cf52f9bafc6.36771342</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D48DDF13-58F8-40AD-A248-08DF59E9A0AA</gtr:id><gtr:title>Deep sequencing of viral genomes provides insight into the evolution and pathogenesis of varicella zoster virus and its vaccine in humans.</gtr:title><gtr:parentPublicationTitle>Molecular biology and evolution</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/03f50fdda9533c73c407c979b78d57e2"><gtr:id>03f50fdda9533c73c407c979b78d57e2</gtr:id><gtr:otherNames>Depledge DP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0737-4038</gtr:issn><gtr:outcomeId>545ba503861c55.58805226</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7A74636A-CD69-4B50-B771-AAE0CE25F3C1</gtr:id><gtr:title>TRIM22 inhibits influenza A virus infection by targeting the viral nucleoprotein for degradation.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/67f6a49d89030d49da8ab007e4a081ae"><gtr:id>67f6a49d89030d49da8ab007e4a081ae</gtr:id><gtr:otherNames>Di Pietro A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>545cf675846cb4.54365678</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CAFFBFED-6BF0-4D8D-8758-C9994C4807B7</gtr:id><gtr:title>HIV-1 evades innate immune recognition through specific cofactor recruitment.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/34c1e8ababaaac31f24b1fb218be5bbb"><gtr:id>34c1e8ababaaac31f24b1fb218be5bbb</gtr:id><gtr:otherNames>Rasaiyaah J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>545cf024a9da14.90917005</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7C236FD4-D3DA-42CA-9B29-470C21B3A804</gtr:id><gtr:title>Immunotherapy of HCC metastases with autologous T cell receptor redirected T cells, targeting HBsAg in a liver transplant patient.</gtr:title><gtr:parentPublicationTitle>Journal of hepatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bd2ca761a141ca7db238491b9127a7d8"><gtr:id>bd2ca761a141ca7db238491b9127a7d8</gtr:id><gtr:otherNames>Qasim W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0168-8278</gtr:issn><gtr:outcomeId>5461fe2140e195.66589283</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>953EF217-8F45-4953-820F-6C0422B3CF2E</gtr:id><gtr:title>Wilms' Tumour 1 (WT1) peptide vaccination in patients with acute myeloid leukaemia induces short-lived WT1-specific immune responses.</gtr:title><gtr:parentPublicationTitle>British journal of haematology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b6edbf63ed60ec50dcf00c4121c43bfc"><gtr:id>b6edbf63ed60ec50dcf00c4121c43bfc</gtr:id><gtr:otherNames>Uttenthal B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0007-1048</gtr:issn><gtr:outcomeId>5461feced8ad72.96654439</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6FAD1D1C-0335-4C1A-8FCF-A1F14B9B61BA</gtr:id><gtr:title>Endoplasmic reticulum degradation-enhancing a-mannosidase-like protein 1 targets misfolded HLA-B27 dimers for endoplasmic reticulum-associated degradation.</gtr:title><gtr:parentPublicationTitle>Arthritis &amp; rheumatology (Hoboken, N.J.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/439b5ba9e59cc5db5573c4d16339e4ab"><gtr:id>439b5ba9e59cc5db5573c4d16339e4ab</gtr:id><gtr:otherNames>Guiliano DB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2326-5191</gtr:issn><gtr:outcomeId>545ce81ebb64f2.77214785</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>869FA6E9-6B96-4317-82ED-A7F1C13310FD</gtr:id><gtr:title>Monsef Benkirane awarded 2013 Ming K. Jeang Foundation Retrovirology Prize: landmark HIV-1 research honoured.</gtr:title><gtr:parentPublicationTitle>Retrovirology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c1806d57777bec30b4d217f5aa67467e"><gtr:id>c1806d57777bec30b4d217f5aa67467e</gtr:id><gtr:otherNames>Berkhout B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1742-4690</gtr:issn><gtr:outcomeId>545b9d0ec101e2.12860597</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>448C4005-1E5C-471E-8B1F-918AB5FD6188</gtr:id><gtr:title>Early biodistribution and persistence of a protective live attenuated SIV vaccine elicits localised innate responses in multiple lymphoid tissues.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/02766ea99fdc02271ba31905900e4123"><gtr:id>02766ea99fdc02271ba31905900e4123</gtr:id><gtr:otherNames>Ferguson D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>545ce648427cc1.54108412</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>18BD06E6-24A0-48AC-90E8-3F852F3265A3</gtr:id><gtr:title>Human MHC Class I-restricted high avidity CD4T cells generated by co-transfer of TCR and CD8 mediate efficient tumor rejection in vivo.</gtr:title><gtr:parentPublicationTitle>Oncoimmunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6ae03fe329f6f39f6142945d9f563e49"><gtr:id>6ae03fe329f6f39f6142945d9f563e49</gtr:id><gtr:otherNames>Xue SA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2162-4011</gtr:issn><gtr:outcomeId>5461ff8162a007.66780775</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AFE6B73D-BEF2-4048-9536-3DA31F43DFAE</gtr:id><gtr:title>Genome Sequence of Human Herpesvirus 7 Strain UCL-1.</gtr:title><gtr:parentPublicationTitle>Genome announcements</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/445e89510add42a0b7afe91dfd55d3ee"><gtr:id>445e89510add42a0b7afe91dfd55d3ee</gtr:id><gtr:otherNames>Donaldson CD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:outcomeId>545ba70ba03f76.49983207</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ECE23C82-762C-42B2-BC48-A27C17EF568A</gtr:id><gtr:title>Heat shock protein 90 controls HIV-1 reactivation from latency.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/16a723b10317ba9aca23158c9a6c8606"><gtr:id>16a723b10317ba9aca23158c9a6c8606</gtr:id><gtr:otherNames>Anderson I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>545b9c57bbc1f2.55365152</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6DCB914C-A235-44BE-9E3D-7A300CAEB279</gtr:id><gtr:title>Vpx complementation of 'non-macrophage tropic' R5 viruses reveals robust entry of infectious HIV-1 cores into macrophages.</gtr:title><gtr:parentPublicationTitle>Retrovirology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/292b41fa56f474420b9e8bde21def9a9"><gtr:id>292b41fa56f474420b9e8bde21def9a9</gtr:id><gtr:otherNames>Mlcochova P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1742-4690</gtr:issn><gtr:outcomeId>545ce9c12b7844.43410502</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F5BECAE8-DD7B-4F49-9714-68B6F73D2AC2</gtr:id><gtr:title>SAMHD1-dependent retroviral control and escape in mice.</gtr:title><gtr:parentPublicationTitle>The EMBO journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9f73bda9f22c7c74fa4a798aa3795187"><gtr:id>9f73bda9f22c7c74fa4a798aa3795187</gtr:id><gtr:otherNames>Rehwinkel J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0261-4189</gtr:issn><gtr:outcomeId>545cf430c3bb39.88718688</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>037AF249-C4DA-430D-BBE2-503C0BE3114E</gtr:id><gtr:title>HIV-1 capsid undergoes coupled binding and isomerization by the nuclear pore protein NUP358.</gtr:title><gtr:parentPublicationTitle>Retrovirology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c660668f7b12ef3922555af6a0e45cc5"><gtr:id>c660668f7b12ef3922555af6a0e45cc5</gtr:id><gtr:otherNames>Bichel K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1742-4690</gtr:issn><gtr:outcomeId>545cf2f6a667e1.20211898</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6A9E8840-6EDD-45E8-8DF0-9E000F014E20</gtr:id><gtr:title>Obituary: Kuan-Teh Jeang.</gtr:title><gtr:parentPublicationTitle>Retrovirology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c1806d57777bec30b4d217f5aa67467e"><gtr:id>c1806d57777bec30b4d217f5aa67467e</gtr:id><gtr:otherNames>Berkhout B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1742-4690</gtr:issn><gtr:outcomeId>545b9ce25dc589.14488349</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1A24FE0F-6C25-4955-9017-0E99AAB7D7C6</gtr:id><gtr:title>Harnessing alveolar macrophages for sustained mucosal T-cell recall confers long-term protection to mice against lethal influenza challenge without clinical disease.</gtr:title><gtr:parentPublicationTitle>Mucosal immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e8005ca9db27435e99e117da5712d43"><gtr:id>5e8005ca9db27435e99e117da5712d43</gtr:id><gtr:otherNames>Macdonald DC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1933-0219</gtr:issn><gtr:outcomeId>5462276a00fcb7.31134393</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AAC7207D-ADFA-48EC-814E-56A1BB5D7981</gtr:id><gtr:title>Interactions between HIV-1 and the cell-autonomous innate immune system.</gtr:title><gtr:parentPublicationTitle>Cell host &amp; microbe</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c9d8dc102629560a2c32a6e4c03990a0"><gtr:id>c9d8dc102629560a2c32a6e4c03990a0</gtr:id><gtr:otherNames>Towers GJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1931-3128</gtr:issn><gtr:outcomeId>545ce8c5b780d7.14999633</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>66F74DA8-7EB9-430A-A5B4-A7358E83C3C4</gtr:id><gtr:title>RNA-seq analysis of host and viral gene expression highlights interaction between varicella zoster virus and keratinocyte differentiation.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9f960dc64663392005f3fbcba53da956"><gtr:id>9f960dc64663392005f3fbcba53da956</gtr:id><gtr:otherNames>Jones M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>545ba41f40f0b9.51180893</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6A0CCB12-8C91-4318-90CF-13E8478EAAE4</gtr:id><gtr:title>Upregulation of TRIM5a gene expression after live-attenuated simian immunodeficiency virus vaccination in Mauritian cynomolgus macaques, but TRIM5a genotype has no impact on virus acquisition or vaccination outcome.</gtr:title><gtr:parentPublicationTitle>The Journal of general virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2d601c726d34be556fecbbd27cb08186"><gtr:id>2d601c726d34be556fecbbd27cb08186</gtr:id><gtr:otherNames>Mattiuzzo G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-1317</gtr:issn><gtr:outcomeId>545cf7c8c7a9a9.67726993</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0501446</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>DD81206B-5EB4-4BCC-AEF7-808A64606E0E</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>5.2  Cellular and gene therapies</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>